InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.490
0.00 (0.00%)
At close: Jun 18, 2026, 4:00 PM EDT
1.452
-0.038 (-2.56%)
After-hours: Jun 18, 2026, 6:15 PM EDT
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $6.79 million as of June 18, 2026. Its market cap has increased by 69.32% in one year.
Market Cap
6.79M
Enterprise Value
1.96M
1-Year Change
69.32%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since May 6, 2014, InMed Pharmaceuticals's market cap has decreased from $9.40M to $6.79M, a decrease of -27.81%. That is a compound annual growth rate of -2.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 6.65M | 58.69% |
| Dec 31, 2025 | 4.19M | 22.12% |
| Dec 31, 2024 | 3.43M | 57.02% |
| Dec 29, 2023 | 2.19M | -31.94% |
| Dec 30, 2022 | 3.21M | -82.66% |
| Dec 31, 2021 | 18.52M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apimeds Pharmaceuticals US | 17.66M |
| China SXT Pharmaceuticals | 14.98M |
| Gelteq | 13.17M |
| Caring Brands | 12.09M |
| Biofrontera | 11.55M |
| Akanda | 10.21M |
| cbdMD | 7.01M |
| RedHill Biopharma | 4.04M |